Linagliptin Impurity 92 | CAS 216854-24-9 - Request Quote
Linagliptin Impurity 92
| SZ CAT No: | SZ-L024147 |
| CAS No | 216854-24-9 |
| Mol.F. | C17H26N2O2 |
| Mol.Wt. | 290.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linagliptin Impurity 92 is chemically Tert-butyl (S)-(1-benzylpiperidin-3-yl)carbamate. Linagliptin Impurity 92 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 92 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 216854-24-9
Purchase 216854-24-9
Order 216854-24-9
Enquire 216854-24-9
price of 216854-24-9
216854-24-9 Supplier
216854-24-9 Manufacturer
216854-24-9 Exporter
buy high quality Linagliptin Impurity 92
Purchase Linagliptin Impurity 92
Linagliptin Impurity 92 suppliers
Linagliptin Impurity 92 manufacturers
Linagliptin Impurity 92 price
Order Linagliptin Impurity 92
Enquire Linagliptin Impurity 92
Linagliptin Impurity 92 cost
Linagliptin Impurity 92 Supplier
Linagliptin Impurity 92 Distributor
Linagliptin Impurity 92 for Method Validation
Linagliptin Reference Standard
Linagliptin Impurity 92 for ANDA Filing
Linagliptin Impurity 92 for Forced Degradation Studies
Linagliptin Impurity 92 Identification Standards
Linagliptin Impurity 92 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


